Cost‐effectiveness of the tandem t: Slim <scp>X2</scp> with control‐<scp>IQ</scp> technology automated insulin delivery system in children and adolescents with type 1 diabetes in Sweden
Initiation of CIQ use in children with type 1 diabetes is cost-saving, besides previously shown improved glycaemic control, and increased quality of life. Further investigations are needed to more fully elucidate the cost-effectiveness of these technologies in different countries with existing differences in payment models.
Authors
- Kristian Bolin (ORCID: https://orcid.org/0000-0003-1682-295X)
- Peter Adolfsson (ORCID: https://orcid.org/0000-0001-7615-9737)
- Alina Heringhaus
- Karin Sjunnesson
- Laila Mehkri
Institutions
- Hallands sjukhus Kungsbacka (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1111/dme.15432
- Citations
- 6
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.15
Funders
- Novo Nordisk